Body composition in patients on haemodialysis: Relationship between the type of haemodialysis and inflammatory and nutritional parameters;Composición corporal en pacientes en hemodiálisis: Relación con la modalidad de hemodiálisis, parámetros inflamatorios y nutricionales

Nefrologia

Volumn 32, Issue 4, 2012, Pages 467-476

  Gallar Ruiz, Paloma ^a   Di Gioia, M Cristina ^a   Lacalle, Concepción ^a   Rodríguez Villareal, Isabel ^a   Laso Arias, Nuria ^a   Hinostroza Yanahuaya, Julie ^a   Oliet Pala, Aniana ^a   Herrero Berron, Juan C ^a   Ortega Marcos, Olimpia ^a   Ortiz Libreros, Milagros ^a   Mon Mon, Carmen ^a   Cobo Jaramillo, Gabriela ^a   Vigil Medina, Ana ^a  

^a HOSPITAL SEVERO OCHOA   (Spain)

Author keywords

Adiponectin; Bioimpedance; Hemodiafiltration; Hemodialysis; Interleukin 6.; Leptin

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; AUTACOID; BIOLOGICAL MARKER; CREATININE; IL6 PROTEIN, HUMAN; INTERLEUKIN 6; LEPTIN; PLASMA PROTEIN; TRANSFERRIN;

AGED; ARTICLE; BLOOD; BODY COMPOSITION; BODY MASS; CHRONIC KIDNEY FAILURE; CROSS-SECTIONAL STUDY; ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; FEMALE; HEMODIAFILTRATION; HUMAN; MALE; METABOLIC DISORDER; METHODOLOGY; MIDDLE AGED; NUTRITIONAL STATUS; OBESITY; RENAL REPLACEMENT THERAPY;

ADIPOKINES; ADIPONECTIN; AGED; BIOLOGICAL MARKERS; BLOOD PROTEINS; BODY COMPOSITION; BODY MASS INDEX; CREATININE; CROSS-SECTIONAL STUDIES; DIELECTRIC SPECTROSCOPY; FEMALE; HEMODIAFILTRATION; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; LEPTIN; MALE; MIDDLE AGED; NUTRITIONAL STATUS; OVERWEIGHT; RENAL DIALYSIS; TRANSFERRIN; WATER-ELECTROLYTE IMBALANCE;

EID: 84867668666     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/Nefrologia.pre2012.Mar.11219     Document Type: Article

References (40)

1. Wen CP, Cherg TY, Tsai MK. All-cause mortality attributable to chronic kidney disease: A prospective cohort study based on 462293 adults in Taiwan. Lancet 2008;371:2173-82.
2. Charra B. "Dry weight" in dialysis: The history of a concept. Nephrol Dial Transplant 1998;7:1882-5.
3. Wizemann V, Wabel P, Channey P, Zaluska W, Moiss L, Rodes Ch, et al. The mortality risk of overhidration in haemodialysis patients. Nephrol Dial Transplant 2009;24:1574-9.
4. Adams KF, Schatzkin A, Harris TB, Klpnis V, Mouw T, Ballard-Babaasash R. Overweight, obesity and mortality in a large orospective cohort of persons 50 to 71 years old. N Engl J Med 2006;355:763-78.
5. Kalantar-Zadeh K, Kopple JD. Obesity paradox in patients on maintenance dialysis. Contrib Nephrol 2006;151:57-69.
6. Kaysen GA, Kotanko P, Zhu F, Sarkar SR, Heymsfield SB, Kuhlmann MK, et al. Relationship between adiposity and cardiovascular risk factors in prevalent hemodialysis patients. J Ren Nutr 2009;19(5):357-64.
7. Axelsson J, Stenvinkel P. Role of mass and adipokines in chronic kidney disease. Curr Opin Nephrol Hypertens 2008;17(1):25-31.
8. Considine RV, Sinha MK, Heiman ML, Kviauciunas A, Stephens TW, Inle MR. Serum immunoreactive-leptin concentrations in normal weight and obese hummans. N Engl J Med 1996;334:292-6.
9. Heimbürger O, Lönnquist F, Danielsson A, Nordenströn J, Stenvinker P. Serum immunoreactive leptine concentrations and its relation to the body fat content in chronic renal failure. J Am Soc Nephrol 1997;8:1423-30.
10. Mandolfo S, Borlandelli S, Imbasciati E. Leptin and beta-2 microglobulin kinetics with three different dialysis modalities. Int Artif Organs 2006;29:949-55.
11. Kim S, Oh KH, Chin HJ, Na KY, Chae DW, Ahn C, et al. Effective removal of leptin via hemodiafiltration with online endogenous reinfusion therapy. Clin Nephrol 2009;72:442-8.
12. Wiecek A, Adamczak M, Chudek J. Adiponectin-an adipokine with unique metabolic properties. Nephrol Dial Transplant 2007;22:981-8.
13. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C-reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 1996;312:1061-5.
14. Zoccalli C, Benedetto FA, Mallamaci F, Trippei G, Fermo I, Focá A, et al. Inflammation is associated with carotid atherosclerosis in dialysis patients. Creed investigators. Cardiovascular risk extended evaluation in dialysis patients. J Hypertens 2000;18:1207-13.
15. Hasuike Y, Nonoguchi H, Ito K, Kitamura R, Nanami M, Tokuyama M, et al. Interleukin-6 is a predictor of mortality in stable hemodialysis patients. Am J Nephrol 2009;30:389-98.
16. Charlson ME, Pompei P, Ales KI. A new method of classifying prognostic comorbidity in longitudinal studies. Development and validation. J Chronic Dis 1987;40:373-83.
17. Wabel P, Moissi U, Chamney P, Jirka T, Machek P, Ponce P, et al. Towards improved cardiovascular management: The necessity of combining blood pressure and fluid overload. Nephrol Dial Transplant 2008;23:2965-71.
18. Malgorzewicz S, Aleksandrowicz-Wrona E, Owczarzack A, Debska-Slizien A, Rutkowski B, Lysiak-Szydlowska W. Adipokines and nutritional status for patients on maintenance hemodialysis. J Ren Nutr 2010;20(5):303-8.
19. Demirci MS, Demirci C, Ozogan O, Kircelli F, Akcicek F, Basci A, et al. Relations between malnutrition-inflammation-atherosclerosis and volume status. The usefulness of bioimpedance analysis in peritoneal dialysis patients. Nephrol Dial Transplant 2011;26(5):1708-16.
20. Arita Y, Kihara S, Occhi N. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79-93.
21. Tamei N, Ogawa T, Ishida H, Ando Y, Nitta K. Relationship of high-molecular-weight adiponectine levels to visceral fat accumulation in hemodialysis patients. Intern Med 2010;49:299-305.
22. Cordeiro AC, Queshri AR, Stenvinkel P, Heimbürger O, Axelsson J, Bárány P, et al. Abdominal fat deposition is associated with increased inflammation, protein-energy wasting and worse outcome in patients undergoing haemodialysis. Nephrol Dial Transplant 2010;25:562-8.
23. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S. Adiponectine, metabolic risk factors and cardiovascular event among patients with end-stage renal disease. J Am Soc Nephrol 2002;13:134-41.
24. Antuness AA, Delatim Vannini F, de Arruda Silveira LV, Martin LC, Barretti P, Caramori JC. Influence of protein intake and muscle mass on survival in chronic diálisis patients. Ren Fail 2010;32(9):1055-9.
25. Gil C, Lucas C, Possante C, Jorge C, Gomes F, Candeias M, et al. On-line haemodiafiltration decreases serum TNFalfa levels in haemodialysis patients. Nephrol Dial Transplant 2003;18:447-8.
26. Van Tellingen A, Grooterman MP, Bartels PC, Van Limbeek J, Van Guldener C, Ter Wee PM, et al. Long-term reduction of plasma homocysteine levels by superflux dialyzers in hemodialysis patients. Kidney Int 2001;59:342-7.
27. Beerenhout CH, Luik AJ, Jeuken-Mertens SG, Bekers O, Menheere P, Hover L, et al. Predilution on-line haemodiafiltration vs low-flux haemodialysis: A randomized prospective study. Nephrol Dial Transplant 2005;20:1155-63.
28. Penne EL, Blankestjin PJ, Blots ML, van der Dorpel MA, Grooteman MP, Nubé MJ, et al. Effect of increased convective clearance by on-line hemodiafiltration on all cause and cardiovascular mortality in chronic hemodialysis patients-The Dutch convective transport study (CONTRAST): rationale and design of a randomised controlled trial. Curr Control Trials Cardiovasc Med 2005;6:8.
29. Gracia-Iguacel C, Gallar P, Qureshi AR, Ortega O, Mon C, Ortiz M, et al. Vitamin D deficiency in dialysis patients: Effect of dialysis modality and implications on outcome. J Ren Nutr 2010;20:359-67.
30. Ledebo I, Blankestin PJ. Haemodiafiltration-Optimal efficiency and safety. NDT Plus 2010;3:8-16.
31. Blankestijn PJ, Ledebo I, Cannaud B. Hemodiafiltration: Clinical evidence and remaining questions. Kidney Int 2010;77(7):581-7.
32. Teruel JL. Convección versus difusión: ¿Ha llegado el momento del cambio? Nefrologia 2009;29(6):594-603.
33. Madwell F. Convección versus difusión: ¿Ha llegado el momento del cambio? Nefrologia 2009;29(6):589-93.
34. Locatelli F, Martin-Malo A, Hannedouche T, Loueiro A, Papadimitriou M, Wizeman V, et al. Effect of membrana permeability on survival of hemodiálisis patients. J Am Soc Nephrol 2009;20:645-54.
35. Mandolfo S, Borlandelli S, Imbasciati E. Leptin and beta2-microglobulin kinetics with three different dialysis modalities. Int J Artif Organs 2006;29:949-55.
36. Vilar E, Fry AC, Tattersall JE, Greenwood RN, Farrington K. Long-term outcomes in online hemodiafiltration and high flux hemodialysis: A comparative analysis. Clin J Am Soc Nephrol 2009;4(12):1944-53.
37. Ortega O, Rodriguez I, Gracia C, Sanchez M, Lentisco C, Mon c, et al. Strict volume control and longitudinal changes in cardiac biomarker levels in hemodialysis patients. Nephron Clin Pract 2009;113:c96-c103.
38. Nordfors L, Lönnqvist F, Heimbürger O, Danielsson A, Schalling M, Stenvinkel P. Low Leptin gene expression and hyperleptinemia in chronic renal failure. Kidney Int 1998;54:1267-75.
39. Demirci MS, Demirci C, Ozdogan O, Kircelli F, Akcicek F, Basci A, et al. Relations between malnutrition-inflammation-atherosclerosis and volume status. The usefulness of bioimpedance analysis in peritoneal dialysis patients. Nephrol Dial Transplant 2011;26(5):1708-16.
40. Devolder I, Verleysen A, Vijy D, Vanholder R, Van Biesen W. Body composition, hydratation, and related parameters in hemodialysis versus peritoneal dialysis. Perit Dial Int 2010;30:208-14.